| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/27/2004 | WO2003006033A3 Herbal formulation |
| 05/27/2004 | WO2003004604A3 Phage displayed pdz domain ligands |
| 05/27/2004 | WO2003003985A3 Polyvalent conjugate vaccine for cancer |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002081413A3 One dimensional unichemo protection (ucp) in organic synthesis |
| 05/27/2004 | WO2002060480A9 Methods for treating or preventing skin disorders using cd2-binding agents |
| 05/27/2004 | WO2002043478A8 Transgenic transchromosomal rodents for making human antibodies |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102804 Apparatus and methods for endoscopic surgical procedures |
| 05/27/2004 | US20040102611 For treatment of human diseases; drug screening; bllt analysis; genetic engineering; kits |
| 05/27/2004 | US20040102607 Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040102407 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 05/27/2004 | US20040102381 Methods of altering the binding affinity of a peptide to its receptor |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102372 Therapeutic antiangiogenic compositions and methods |
| 05/27/2004 | US20040101965 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/27/2004 | US20040101919 Detecting cell wall anchored surface proteins and developing vaccines to diagnose, prevent and treat enterococcus, streptococcus, staphylococcus and bacillus infections |
| 05/27/2004 | US20040101915 Diagnosis and treatment of chemoresistant tumors |
| 05/27/2004 | US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/27/2004 | US20040101899 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101862 Comprises flaviviral polypeptide for use in the treatment cancer and viral diseases |
| 05/27/2004 | US20040101836 Amplification, transfection nucleic acids; genetic engineering; diagnosis of cancer; |
| 05/27/2004 | US20040101827 Methods of infection with hepatitis c virus |
| 05/27/2004 | US20040101537 Mixture of oligonucleotide and fine particles of biodegradation polymer; concurrent administering of protein antigen |
| 05/27/2004 | US20040101536 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/27/2004 | US20040101534 Adjuvant-free peptide vaccine |
| 05/27/2004 | US20040101533 Fusion protein; antitumor, anticancer agenst |
| 05/27/2004 | US20040101532 Methods and compositions for heat shock protein mediated immunotherapy of melanoma |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | US20040101527 Complexing monoclonal antibodies with antigens; removal leukocytes; restenosis therapy; antiproliferative agents |
| 05/27/2004 | US20040101522 Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo |
| 05/27/2004 | US20040101513 Enhancement of immune response to vaccine by interferon alpha |
| 05/27/2004 | DE10147638B4 Leukozyten-Inaktivierungs-Modul (LIM) Leukocyte inactivation module (LIM) |
| 05/27/2004 | CA2757475A1 Compositions and methods for the treatment of natural killer cell related diseases |
| 05/27/2004 | CA2506090A1 Method of obtaining conjugate vaccines and vaccine compositions containing same |
| 05/27/2004 | CA2505931A1 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 05/27/2004 | CA2505724A1 Malaria vaccine |
| 05/27/2004 | CA2505125A1 Assay for autoantibodies to folate receptors |
| 05/27/2004 | CA2504903A1 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | CA2504818A1 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 05/27/2004 | CA2504768A1 Compounds and methods for modulating functions of classical cadherins |
| 05/27/2004 | CA2503303A1 Flavivirus fusion inhibitors |
| 05/27/2004 | CA2501077A1 Polysaccharide vaccine for staphylococcal infections |
| 05/27/2004 | CA2497268A1 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/27/2004 | CA2492103A1 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1422238A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421947A1 p53 vaccine |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421184A2 Live attenuated strains of prrs virus |
| 05/26/2004 | EP1421178A1 Improved methods for producing oocysts |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421118A1 A method for the treatment or prevention of bone erosion |
| 05/26/2004 | EP1421116A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420828A2 Lipophilic drug compositions |
| 05/26/2004 | EP1420825A2 Immunomodulatory compounds and methods of use thereof |
| 05/26/2004 | EP1420823A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 05/26/2004 | EP1420822A2 Modified vaccinia virus ankara for the vaccination of neonates |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420820A2 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 05/26/2004 | EP1420819A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 05/26/2004 | EP1420818A1 Antigenic compositions |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420810A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420636A2 Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP0971741B1 Use of avian antibodies |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0929300B1 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1499982A Use of Il-18 inhibitors for treatment and/or prevention of heart disease |
| 05/26/2004 | CN1499933A Improved anti-inflammatory herbal compsn. and method of use |
| 05/26/2004 | CN1498963A Method for producing virus like granules of human papilloma virus |
| 05/26/2004 | CN1498894A Variable region gene in heavy chain and light chain of anti Pgp monoclone antibody |
| 05/26/2004 | CN1498658A Preparation of high-performance noncellular vaccine and usage |
| 05/26/2004 | CN1151377C Method of diagnosing and treating epithelioma |